Tag Archive for lymphoma
The Jerusalem-based cancer treatment company, KAHR Medical, recently received regulatory approval to initiate a Phase-I/IIa trial in lymphoma treatment.
By Globes Staff
Drug development company KAHR Medical Ltd has raised $12 million in a Series B financing round. The entire financing round will total $15 million, and it is anticipated that the remaining $3 million will be raised February 15th. The Jerusalem-based developer of cancer and auto-immune treatments was founded by Hadasit – the Technology Transfer Company of Hadassah Medical Organization unit Hadasit Bio Holdings Ltd. (TASE:HDST; Bulletin Board: HADSY).
Continue Reading »
Proceeds of the new financing will be used primarily to fund the clinical development of KAHR’s lead product, KAHR-102, which recently received regulatory approval in Israel to initiate a Phase-I/IIa trial in lymphoma, as well as pre-clinical development of KAHR-101 and new pipeline programs.Korea
cancer – illustrative